Pre-clinical models of infectious diseases; task C12 lymphatic filariasis vaccine (lfguard) efficacy trial in dogs
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
University Of Georgia Research Foundation, Inc. UEI NMJHD63STRC5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $356,983
Award facts
- Contract value 100% obligated
- $356,983.37 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Athens, GA 30602, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$13,970 | |
| Close Out | -$53,501 | |
| Original award | $424,455 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $356,983.37 delivery order to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) on September 16, 2020, for Task C12 of the Preclinical Models of Infectious Diseases contract. This task specifically focuses on conducting an efficacy trial for LFGuard, a lymphatic filariasis vaccine, using canine models. The work will be performed in Athens, Georgia, and is structured as a cost-no-fee delivery order under the larger NIAID Preclinical Models of Infectious Diseases Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, which runs through 2024. No set-aside designation was applied to this award, allowing full and open competition among eligible contractors.
UGA Research Foundation, a non-profit research foundation serving as the sponsored research arm of the University of Georgia, is well-positioned to execute this work given its extensive experience managing complex infectious disease research programs for NIAID and other federal agencies. The foundation holds the prime position on the $146.3 million NIAID IDC, which encompasses four primary task areas including animal and non-traditional animal models to support pandemic preparedness efforts. This particular delivery order represents a component of that broader research infrastructure, contributing to the evaluation of vaccines and therapeutics for priority infectious diseases through rigorous pre-clinical animal model testing.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to University Of Georgia Research Foundation, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $356,983 on 75N93020F00003.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under HHSN272201700035I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award